Overview
Shared Decision Making and Improved Patient Participation in PAH Care: Strategies for Community and Specialist Practitioners
Insights and Updates in PAH Treatment: A Series Curriculum
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
In this digital Q&A interview, expert faculty Dan Schuller, MD provides his perspective on collaborative strategies between provider and patient to increase PAH treatment adherence and improve PAH outcomes via shared clinical decision making. A current PAH patient will also share her experience with diagnosis and related patient insights on shared decision making. This is the second in a series of two educational activities on PAH to be released in 2018.
This activity is designed for primary care physicians, cardiologists, cardiopulmonologists, and other allied healthcare professionals interested in PAH.
The purpose of this activity is to educate primary care physicians, internists, cardiologists, pulmonologists, cardiopulmonologists, and other allied healthcare professionals interested improving interdisciplinary PAH/PH care across clinical settings (ie, coordinating care between academic specialty PAH/PH centers and community practice settings.)
Upon completion of this activity, participants will be able to:
• Describe optimal clinical strategies for improving detection of PAH at earlier stages of the disease.
• Discuss patient counseling and management strategies for team-based, supportive PAH care across disease stages and functional classes.
• Describe optimal clinical strategies for improving detection of PAH at earlier stages of the disease.
• Discuss patient counseling and management strategies for team-based, supportive PAH care across disease stages and functional classes.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Dan Schuller, MD
Chair and Professor,
Department of Internal Medicine Texas Tech University Health Sciences Center in El Paso– Transmountain
Paul L. Foster School of Medicine
El Paso, Texas
Chair and Professor,
Department of Internal Medicine Texas Tech University Health Sciences Center in El Paso– Transmountain
Paul L. Foster School of Medicine
El Paso, Texas
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Dan Schuller, MD (Faculty)
Speakers' Bureau: Bayer HealthCare Pharmaceuticals Inc., Gilead Sciences, Inc.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Bardoxolone methyl (Phase III)
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Laurie Novoryta at LNovoryta@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.